Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents

Blood (2024) 144 (Supplement 1): 3541.

https://doi.org/10.1182/blood-2024-199077

Published: 2024

Journal Articles

Prognostic Impact of Graft-Versus-Host Disease on Allogeneic Transplantation for CMML Focusing on Conditioning Intensity

Hidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, Shuhei Kurosawa, Yasunobu Nagata, Yutaka Shimazu, Tomoaki Ueda, Naoyuki Uchida, Noriko Doki, Tetsuya Nishida, Ken-ichi Matsuoka, Masatsugu Tanaka, Makoto Yoshimitsu, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Takayoshi Tachibana

Blood (2024) 144 (Supplement 1): 6755.

https://doi.org/10.1182/blood-2024-193699

Published: 2024

Journal Articles

Optimal Procedures of Allogeneic Transplantation for BCR::ABL1 -Negative Atypical Chronic Myeloid Leukemia

Hidehiro Itonaga, Yasushi Miyazaki, Takeshi Kondo, Yutaka Shimazu, Jun Aoki, Shuhei Kurosawa, Takashi Ikeda, Tetsuya Eto, Naoyuki Uchida, Hideyuki Nakazawa, Koji Kawamura, Junya Kanda, Yoshiko Atsuta, Takayoshi Tachibana

Blood (2024) 144 (Supplement 1): 4548.

https://doi.org/10.1182/blood-2024-193697

Published: 2024

Journal Articles

Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy

Kimimori Kamijo, Yoshimitsu Shimomura, Takayoshi Tachibana, Yuho Najima, Jun Aoki, Yu Akahoshi, Masatsugu Tanaka, Noriko Doki, Naoyuki Uchida, Hiroyuki Ohigashi, Hikaru Kobayashi, Shuichi Ota, Miho Nara, Shinichiro Fujiwara, Yasuo Mori, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Yasuyuki Arai

Blood (2023) 142 (Supplement 1): 4958.

https://doi.org/10.1182/blood-2023-180602

Published: 2023

Journal Articles

Outcomes after Hematopoietic Cell Transplantation for T-Lineage Acute Lymphoblastic Leukemia and Lymphoma: A Cooperative Study from the Adult Acute Lymphoblastic Leukemia Working Group and the Adult Malignant Lymphoma Working Group of the Japanese Society for Transplantation and Cellular Therapy

Blood (2023) 142 (Supplement 1): 899.

https://doi.org/10.1182/blood-2023-184709

Published: 2023

Journal Articles

A Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 3606.

https://doi.org/10.1182/blood-2023-174312

Published: 2023

Journal Articles

Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT)

Blood (2022) 140 (Supplement 1): 4709–4710.

https://doi.org/10.1182/blood-2022-168458

Published: 2022

Journal Articles

Allogeneic Stem Cell Transplantation Conditioned with Myeloablative Regimens Containing Total Body Irradiation in Adolescent and Young Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Who Were Treated with Pediatric-Type Chemotherapy

Blood (2021) 138 (Supplement 1): 2283.

https://doi.org/10.1182/blood-2021-151855

Published: 2021

Journal Articles

Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Myeloablative Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT)

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-134539

Published: 2020

Journal Articles

Predictive Values of Early ST2 for Acute Graft-Versus-Host Disease and Transplant-Related Complications after Allogeneic Stem Cell Transplantation

Takuya Miyazaki, Ayako Matsumura, MD, Takayoshi Tachibana, Taiki Ando, MD, Megumi Koyama, MD, Satoshi Koyama, MD, Yoshimi Ishii, MD, Hiroyuki Takahashi, MD, Yuki Nakajima, MD, Ayumi Numata, MD, Wataru Yamamoto, MD, Kenji Motohashi, MD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD, Shin Fujisawa, MD, Hideaki Nakajima, MD

Blood (2019) 134 (Supplement_1): 1976.

https://doi.org/10.1182/blood-2019-123262

Published: 2019

Journal Articles

Epidemiology of Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed Myelodysplastic Syndrome

Yoshimitsu Shimomura, MD, Masahiko Hara, Takayoshi Tachibana, MD, Kazuteru Ohashi, MD PhD, Yukiyasu Ozawa, MD PhD, Tetsuya Eto, MD PhD, Naoyuki Uchida, MD PhD, Takehiko Mori, MD PhD, Junya Kanda, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Takayuki Ishikawa, Ken Ishiyama, MD PhD

Blood (2018) 132 (Supplement 1): 3453.

https://doi.org/10.1182/blood-2018-99-113258

Published: 2018

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia with Pre-Transplant Conditioning Using Fludarabine, Reduced-Dose Cyclophosphamide, and Low-Dose Thymoglobulin:Â Ksgct Prospective Study

Shinichi Kako, MD, Yoshinobu Kanda, MD PhD, Makoto Onizuka, MD PhD, Nobuyuki Aotsuka, Kensuke Usuki, MD PhD, Takayoshi Tachibana, MD, Takeshi Kobayashi, MD, Jun Kato, MD, Shingo Yano, MD PhD, Hiroaki Shimizu, MD PhD, Katsuhiro Shono, Masatsugu Tanaka, MD, Shokichi Tsukamoto, MD, Takehiko Mori, MD PhD, Etsuko Yamazaki, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2018) 132 (Supplement 1): 2101.

https://doi.org/10.1182/blood-2018-99-115105

Published: 2018

Journal Articles

Identification of Lymphocyte Subsets Associated with Outcomes in Patients with Hematological Malignancy Following Allogeneic Stem Cell Transplantation: A Single Institute Study

Taiki Ando, MD, Yasufumi Ishiyama, MD, Takayoshi Tachibana, MD, Masatsugu Tanaka, MD, Heiwa Kanamori, MD PhD, Hideaki Nakajima, MD

Blood (2018) 132 (Supplement 1): 2115.

https://doi.org/10.1182/blood-2018-99-112107

Published: 2018

Journal Articles

Impact of the Difference in Body Mass Index at Transplantation from That at Diagnosis for Graft-Versus-Host Disease-Free, Relapse-Free Survival in Acute Myeloid Leukemia

Blood (2016) 128 (22): 3482.

https://doi.org/10.1182/blood.V128.22.3482.3482

Published: 2016

Journal Articles

Prognostic Impact of Delayed Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancy

Heiwa Kanamori, MD, Jun Aoki, MD, Eriko Ogusa, MD, Akiko Negoro, MD, Satoshi Koyama, MD, Takayoshi Tachibana, MD, Masatsugu Tanaka, MD, Hideaki Nakajima, MD PhD

Blood (2016) 128 (22): 3407.

https://doi.org/10.1182/blood.V128.22.3407.3407

Published: 2016

Journal Articles

the Safety and Efficacy of Deferasirox for the Transplant Patients with Iron Overload

Takayoshi Tachibana, MD, Junya Kanda, Shinichiro Machida, MD, Takeshi Saitou, Masatsugu Tanaka, MD, Yuho Najima, Satoshi Koyama, MD, Takuya Miyazaki, MD PhD, Eri Yamamoto, Masahiro Takeuchi, MD PhD, Satoshi Morita, PhD Prof, Yoshinobu Kanda, MD PhD, Heiwa Kanamori, MD, Shinichiro Okamoto, MD PhD

Blood (2016) 128 (22): 2254.

https://doi.org/10.1182/blood.V128.22.2254.2254

Published: 2016

Journal Articles

Prognostic Impact of Pre-Transplant Serum C-Reactive Protein in Patients Receiving a Single-Unit Unrelated Cord Blood Transplantation

Akiko Negoro, MD, Heiwa Kanamori, MD, Jun Aoki, MD, Satoshi Koyama, MD, Takayoshi Tachibana, MD, Masatsugu Tanaka, MD, Hideaki Nakajima, MD

Blood (2016) 128 (22): 5853.

https://doi.org/10.1182/blood.V128.22.5853.5853

Published: 2016

Journal Articles

Body Mass Index Is a Prognostic Factor in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Multi-Institutional Study in Japan

Taiki Ando, MD, Etsuko Yamazaki, MD, Haruka Teshigawara, MD, Fujii Eriko, MD, Yoshimi Ishii, MD, Wataru Yamamoto, MD, Kenji Motohashi, MD, Takayoshi Tachibana, MD, Maki Hagihara, MD, Kenji Matsumoto, MD, Masatsugu Tanaka, Hashimoto Chizuko, MD, Koharazawa Hideyuki, MD, Fujimaki Katsumichi, MD, Jun Taguchi, MD, Naoto Tomita, MD, Hiroyuki Fujita, MD, Heiwa Kanamori, Shin Fujisawa, MD

Blood (2015) 126 (23): 1316.

https://doi.org/10.1182/blood.V126.23.1316.1316

Published: 2015

Journal Articles

The Sil Index Is a Useful Prognostic Indicator for Diffuse Large B-Cell Lymphoma

Blood (2015) 126 (23): 1512.

https://doi.org/10.1182/blood.V126.23.1512.1512

Published: 2015

Journal Articles

Beta-2 Microglobulin As a Strong Prognostic Factor in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone

Blood (2014) 124 (21): 3079.

https://doi.org/10.1182/blood.V124.21.3079.3079

Published: 2014

NARROW

Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents

Prognostic Impact of Graft-Versus-Host Disease on Allogeneic Transplantation for CMML Focusing on Conditioning Intensity

Optimal Procedures of Allogeneic Transplantation for BCR::ABL1 -Negative Atypical Chronic Myeloid Leukemia

Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy

Outcomes after Hematopoietic Cell Transplantation for T-Lineage Acute Lymphoblastic Leukemia and Lymphoma: A Cooperative Study from the Adult Acute Lymphoblastic Leukemia Working Group and the Adult Malignant Lymphoma Working Group of the Japanese Society for Transplantation and Cellular Therapy

A Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation

Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT)

Allogeneic Stem Cell Transplantation Conditioned with Myeloablative Regimens Containing Total Body Irradiation in Adolescent and Young Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Who Were Treated with Pediatric-Type Chemotherapy

Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Myeloablative Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT)

Predictive Values of Early ST2 for Acute Graft-Versus-Host Disease and Transplant-Related Complications after Allogeneic Stem Cell Transplantation

Epidemiology of Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed Myelodysplastic Syndrome

Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia with Pre-Transplant Conditioning Using Fludarabine, Reduced-Dose Cyclophosphamide, and Low-Dose Thymoglobulin:Â Ksgct Prospective Study

Identification of Lymphocyte Subsets Associated with Outcomes in Patients with Hematological Malignancy Following Allogeneic Stem Cell Transplantation: A Single Institute Study

Impact of the Difference in Body Mass Index at Transplantation from That at Diagnosis for Graft-Versus-Host Disease-Free, Relapse-Free Survival in Acute Myeloid Leukemia

Prognostic Impact of Delayed Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancy

the Safety and Efficacy of Deferasirox for the Transplant Patients with Iron Overload

Prognostic Impact of Pre-Transplant Serum C-Reactive Protein in Patients Receiving a Single-Unit Unrelated Cord Blood Transplantation

Body Mass Index Is a Prognostic Factor in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Multi-Institutional Study in Japan

The Sil Index Is a Useful Prognostic Indicator for Diffuse Large B-Cell Lymphoma

Beta-2 Microglobulin As a Strong Prognostic Factor in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only